Press release
Pulmonary Arterial Hypertension Market Global Industry Volume By Region 2014 - 2020
According to the report, the primary driver for the global PAH market is the list of newly-approved drugs and medical products aimed at treating PAH. A large number of medical products are already approved, while more are still in the pipeline. Another factor promoting the growth of the global PAH market is the increasing number of leaps taken in research and development efforts, aided by government policies and other initiatives.
The global pulmonary arterial hypertension (PAH) market is progressing at a high CAGR of 17.90% within a forecast period of 2014 to 2020. This market was recorded at US$4.04 bn in 2013, and is expected to reach US$5.19 bn by the end of 2020. The data is presented in a unique and comprehensive manner in a research report released by Transparency Market Research, titled “Pulmonary Arterial Hypertension (PAH) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
Obtain Report Details @
http://www.transparencymarketresearch.com/pulmonary-arterial-hypertension-therapeutics.html
The report provides a segmented analysis of the global PAH market. These segments are sorted within the categories of drug class and geography. The report also provides an extensive analysis of the pipeline drugs in the global PAH market.
In terms of drug class, the global PAH market is segmented into soluble guanylate cyclase (sGC) stimulators, phosphodiesterase-5 (PDE-5) inhibitors, endothelin receptor antagonists (ERAs), and prostacyclin and prostacyclin analogs. Of these, the report’s authors have put the prostacyclin and prostacyclin analogs segment ahead of the ERA segment, which means that the segment will lead the global PAH market by 2023, surpassing the current leader, ERAs.
The report’s geographical segmentation of the global PAH market reveals Asia Pacific to be the fastest-growing region for the given forecast period. The growth rate of this region is attributed to major opportunities that will be found in Australia, New Zealand, Japan, China, and India. Enterprises operating in these regions could take advantage of these opportunities and increase their profits and presence in the market.
The report, however, states one of the major restraints on the global PAH market as the challenges faced by the Rest of the World PAH market. The report’s study shows that most of the nations in the Rest of the World region possess a low level of awareness of this market’s products. Therefore, this region is showing a much slower growth rate when compared to the regions of North America or Europe.
The key players in the global pulmonary arterial hypertension market are United Therapeutics Corp., Novartis International AG, Pfizer Inc., GlaxoSmithKline plc, Bayer HealthCare, Gilead Sciences Inc., and Actelion Pharmaceuticals Ltd.
Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1181
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market Global Industry Volume By Region 2014 - 2020 here
News-ID: 528792 • Views: …
More Releases from TMR - Healthcare
Clinical Trial Management System (CTMS) Market : Projection of Each Major Segmen …
With companies long having realized that the best way to remain competitive in the pharmaceutical industry is by ploughing back of profits into R&D projects, the demand for clinical trial management systems is expected to see an uptick. While this will help impel the market greatly in the coming years, what also needs to be taken into consideration that the cost of implementing such a system may deter investment decisions.
The…
Electronic Health Records Market : Industry Analysis and Detailed Profiles of to …
The global market for electronic health record (EHR) features a largely fragmented vendor landscape, with the presence of a large number of small and large players and the top five companies cumulatively accounting for a nearly 44% of the overall market in 2016. Leading vendors in the global EHR market are adopting inorganic growth strategies such as mergers and acquisitions to expand their reach across high-growth potential regional markets, consolidate…
Fuel Oil Market Intelligence Report Offers Growth Prospects
The global transportation industry has been growing at a significant pace since the past decade. Companies operating in the transportation industry are the largest consumers of the fuel oil. Apart from this, fuel oil also finds application in the petrochemical industry and petroleum refineries. The building materials industry is also on the rise since many years. The demand for fuel oil is expected to increase from the building materials industry.…
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 202 …
The global composite industry has been expanding significantly in terms of production, technological advancements, and developments. Thermoset resin plays a vital role in the composite industry. Thermoset resins are used extensively in the manufacture of composites; these resins are employed in the fabrication of products for end-use industries such as aerospace, automotive, sporting goods, construction, electronics, and wind energy. The thermoset resin market can be segmented into six resin types:…
More Releases for PAH
Development: Pulmonary Arterial Hypertension (PAH) Market Growth Analysis
The global pulmonary arterial hypertension (pah) market is estimated to surpass $9,670.2 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027.
The report provides all-inclusive analysis of global pulmonary arterial hypertension (pah) market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide…
Pulmonary Arterial Hypertension (PAH) Market Research and Clinical Analysis 2020
Global Pulmonary Arterial Hypertension (PAH) Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Pulmonary Arterial Hypertension (PAH) Market research report identifies the competitive landscape of industries to understand the competition at International level.…
Pulmonary Arterial Hypertension (PAH) Medicine Market (2020-2027) Report Offers …
The research study includes the latest updates about the COVID-19 impact on the Pulmonary Arterial Hypertension (PAH) Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.
The market research report on the global Pulmonary Arterial Hypertension (PAH) Medicine market provides an extensive and…
Pulmonary Arterial Hypertension (PAH) - Market Outlook and Competitive Landscape …
Report Overview
The report provides a comprehensive view of disease events, types, severity, progression, symptoms, risk factors, pathogenesis and treatment guidelines at country level
Comprehensive insight on patient segmentation has been provided into the epidemiology of the Pulmonary Arterial Hypertension (PAH) and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China
Drug utilization and analysis on the current…
Global Pulmonary Arterial Hypertension (PAH) Market| MarketResearchReports.biz
Latest industry research report on: Global Pulmonary Arterial Hypertension (PAH) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V…
Pulmonary Arterial Hypertension (PAH) Market by Key Players
Global Pulmonary Arterial Hypertension (PAH) Market: Snapshot
Pulmonary arterial hypertension (PAH) is a very rare type of progressive disorder related to high blood pressure. However, the rate of incidence of this disorder is gradually gaining traction. Various sources, including WHO and CDC, suggest that the global prevalence of PAH is anticipated to be between 100,000 and 200,000, narrowing down to about 15-50 cases per million heads. There is no permanent cure…
